Saturday, Aug 08, 2020 | Last Update : 08:21 PM IST

137th Day Of Lockdown

Maharashtra49026232728117092 Tamil Nadu2850242275754690 Andhra Pradesh2069601204641842 Karnataka164924842322998 Delhi1427231282324082 Uttar Pradesh113378668341981 West Bengal89666630601954 Bihar7179446294400 Gujarat68855517922604 Assam5549737225132 Rajasthan4941835186763 Odisha4255028698292 Haryana4005433444467 Madhya Pradesh3729827621962 Kerala3170019147103 Jammu and Kashmir2392716218449 Punjab2193014040539 Jharkhand165427503154 Chhatisgarh11408831987 Uttarakhand89015731112 Goa7947559570 Telangana751354330615 Tripura6014408437 Puducherry5123291475 Manipur3466192610 Himachal Pradesh3206200813 Nagaland26578247 Arunachal Pradesh204913263 Chandigarh137482023 Meghalaya10234236 Sikkim8544061 Mizoram5672890
  India   All India  21 Jan 2019  Nano tech to spur research in ayurveda

Nano tech to spur research in ayurveda

THE ASIAN AGE. | RAHUL CHHABRA
Published : Jan 21, 2019, 4:44 am IST
Updated : Jan 21, 2019, 4:45 am IST

The university’s Centre for translational Research excels in applying findings from basic science to enhance human health and well-being.

Jivaji University vice-chancellor Sangita Shukla with AIMIL Pharma’s Sanchit Sharma at the time of signing an agreement for research in ayurveda.
 Jivaji University vice-chancellor Sangita Shukla with AIMIL Pharma’s Sanchit Sharma at the time of signing an agreement for research in ayurveda.

New Delhi: In a first, government recognised Centre for Translational Research of Jiwaji University has entered into an industry tie-up to develop new ayurveda-based medicine formulas using nano technology and market new remedies for hitherto incurable diseases.

Taking a cue from successful industry tie-ups of the Council of Scientific and Industrial Research (CSIR) and Defence Research and Development Organisation (DRDO), Madhya Pradesh government-funded Jiwaji University (NAAC A grade accredited) has signed an agreement with Delhi-based AIMIL Pharmaceuticals to study centuries-old ayurvedic formulations, standardise and authenticate them and use information about their potent ingredients for developing new medicines.

 

“AIMIL will pump in resources, like equipment and technology inputs, to help the university utilise its pool of qualified researchers to its optimal potential,” said AIMIL executive director Sanchit Sharma.

University vice-chancellor Sangita Shukla thanked the Union ayush ministry for promoting research in ayurveda and said, “It is a win-win situation for us. The arrangement will open new avenues for our faculty and students while giving AIMIL access to latest research feedback.”  

The university’s Centre for translational Research excels in applying findings from basic science to enhance human health and well-being.

Former secretary health and former director general Indian Council of Medical Research (ICMR) V. M. Katoch lauded co-ordination between researchers and ayurvedic industry.

 

“Ayurveda is the key to treating some of the incurable diseases. If old formulations are subjected to modern research, we will surely be able to develop world-class medicines with negligible side effects,” said Mr Katoch.

Highlighting the gains from tie-ups between researchers and industry, he cited the example of DRDO developed formulation to treat white skin spots or vitiligo, Lukoskin, and CSIR-developed diabetes formulation called BGR-34. The Union government has tied-up with AIMIL for marketing the two drugs. The CSIR developed  BGR-34, after standardisation and pre-clinical studies conducted jointly by its two labs — Central Institute of Medicinal and Aromatic Plants and National Botanical Research Institute. It is meant to be used by newly-diagnosed diabetes patients for management of the disease. BGR-34, is an add-on or adjuvant to existing diabetes treatment helping to maintain normal blood glucose levels, in addition to improving the immune system, releasing antioxidants and checking free radicals.

 

Tags: jiwaji university, icmr